The future’s green for the University of Nottingham and pharmaceutical giant

The University of Nottingham is working with GlaxoSmithKline (GSK) to establish a carbon neutral laboratory for sustainable chemistry. It is supported by a philanthropic investment of £12million from the pharmaceutical company as part of its initiative to reduce the environmental impact of its manufacturing processes.

The GlaxoSmithKline Carbon Neutral Laboratory for Sustainable Chemistry will focus on research of particular relevance to the pharmaceuticals-based supply chain which complements established expertise at the University. The laboratories will be the focal point for the delivery of sustainability-linked undergraduate courses, training future chemists in cutting-edge ‘greener’ processes, which are increasingly employed within the chemicals industry.

This exciting initiative builds on existing links between GSK and the University, via support for postgraduate chemistry studentships, co-delivery of a module focused upon medicinal chemistry and a pioneering final year laboratory-based module that allows students to actively engage in the drug-discovery process participating in a live GSK-linked research programme.

Related case studies

Reducing blood transfusions to lower patient risk, reduce costs and save lives

More than half a million people in the UK receive a blood transfusion each year and demand is increasing. Our ageing population, and a stringent donor selection process, mean the supply of blood is limited. 40% fewer new donors came forward last year compared with a decade ago. Recognising these challenges, researchers at the University of Edinburgh have shown the benefits of reducing the use of blood transfusions in intensive care and surgery.

Read more >